BCTILs

Breast Cancer TILs scoring

Free · Designed for iPad. Not verified for macOS.

Reference examples, pitfalls, and scoring guidance for Tumour-Infiltrating Lymphocytes (TILs) assessment across the 5–100% range in breast cancer. This app provides pathologists and trainees with a structured reference for scoring Tumour-Infiltrating Lymphocytes (TILs) in breast cancer histopathology. TILs assessment is an increasingly important prognostic and predictive biomarker in breast cancer, particularly in triple-negative and HER2-positive subtypes. Consistent, standardised scoring supports more reliable interpretation across cases and observers. Features: • Curated example slide images spanning the scoring range, from 5% to 100% • Common pitfalls and sources of misinterpretation at each score level • Reference guidance aligned with international scoring recommendations • A quick, accessible tool for calibration and training Intended for use by pathologists, pathology trainees, and researchers as an educational and reference aid. This app is not a diagnostic device and does not replace clinical judgement or established laboratory protocols.

Ratings & Reviews

  • 5.0
    out of 5
    1 Ratings

- New icon - Fixed tab font contrast - Fixed grammar and typos

Version 1.0.24

The developer, Franco Caramia, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .

  • Data Not Collected

    The developer does not collect any data from this app.

    Privacy practices may vary, for example, based on the features you use or your age. Learn More

    Accessibility

    The developer has not yet indicated which accessibility features this app supports. Learn More

    Information

    Seller
    Franco Caramia
    Size
    58.4 MB
    Category
    Medical
    Compatibility
    Requires iOS 15.0 or later.
    • iPhone
      Requires iOS 15.0 or later.
    • iPad
      Requires iPadOS 15.0 or later.
    • iPod touch
      Requires iOS 15.0 or later.
    • Mac
      Requires macOS 12.0 or later and a Mac with Apple M1 chip or later.
    • Apple Vision
      Requires visionOS 1.0 or later.
    Languages
    English
    Age Rating
    4+
    Copyright
    © 2026 International Immuno-Oncology Biomarker Working Group on Breast Cancer
  • Privacy Policy

    • You Might Also Like